FDA Archives - BluePeak Advisors

FDA

In the News…

Unapproved Drugs Initiative Terminated On November 20, 2020 The Department of Health and Human Services terminated the Unapproved Drugs Initiative. The 2006 Unapproved Drug Initiative requires manufacturers to submit drugs…

BluePeak AdvisorsDecember 18, 2020

CMS EOC FDA Part D

Formulary Strategy Planning for 2020-Indication Based Formulary Design Considerations

The 2019 plan year has not commenced, yet plans are already developing formulary strategies for 2020. Indication-based formulary designs will add a new twist for plan sponsors to consider as…

BluePeak AdvisorsDecember 1, 2018

ANOC/EOC CMS FDA HPMS Medicaid Medicare Part D

Indication-Based Formulary Design in CY2020

Beginning in the 2020 contract year (“CY2020”), the Centers for Medicare & Medicaid Services (“CMS”) will permit Part D sponsors to implement indication-based formulary designs that tailor formulary coverage of…

BluePeak AdvisorsSeptember 4, 2018